|
Pharmaceutical Products – Pharmaceutical Framework Discount Agreements According To §130A Paragraph 8 Sgb V. Dak-G /Kkh Active Ingredient Alendronic Acid Atc Who M05ba04,Dak-G /Kkh Active Ingredient Aripiprazole Liquid Atc Who N05ax12,Dak-G /Kkh Active Ingredient Aripiprazole Solid Atc Who N05ax12,Dak-G /Kkh Active Ingredient Azathioprine Solid Atc Who L04ax01,Dak-G /Kkh Active Ingredient Bisoprolol Atc Who C07ab07,Dak-G /Kkh Active Ingredient Bisoprolol And Hydrochlorothiazide Atc Who C07bb07,Dak-G /Kkh Active Ingredient Buprenorphine Sut N02ae01 Atc Who N02ae01,Dak-G /Kkh Active Ingredient Buprenorphine Sut N07bc01 Atc Who N07bc01,Dak-G /Kkh Active Ingredient Buprenorphine Pft 7 Days Atc Who N02ae01,Dak-G /Kkh Active Ingredient Buprenorphine Pft 4 Days Atc Who N02ae01,Dak-G /Kkh Active Ingredient Buprenorphine Pft 3 Days Atc Who N02ae01,Dak-G /Kkh Active Ingredient Celecoxib Atc Who M01ah01,Dak-G /Kkh Active Ingredient Ciclopirox Cre Atc Who D01ae14,Dak-G /Kkh Active Ingredient Ciclopirox Loe Atc Who D01ae14,Dak-G /Kkh Active Ingredient Clopidogrel Atc Who B01ac04,Dak-G /Kkh Active Ingredient Colecalciferol, Combinations With Sodium Fluoride Atc Who A11cc55,Dak-G /Kkh Active Ingredient Cyanocobalamin Ilo/Amp * Atc Who B03ba01,Dak-G /Kkh Active Ingredient Cyanocobalamin Tablets * Atc Who B03ba01,Dak-G /Kkh Active Ingredient Cyproterone Acetate Atc Who G03ha01,Dak-G /Kkh Active Ingredient Diclofenac Atr Atc Who S01bc03,Dak-G /Kkh Active Ingredient Diclofenac Unretarded (> 50 Mg) Atc Who M01ab05,Dak-G /Kkh Active Ingredient Diclofenac, Retarded Atc Who M01ab05,Dak-G /Kkh Active Ingredient Diclofenac Sup Atc Who M01ab05,Dak-G /Kkh Active Ingredient Diclofenac Unretarded Rx Up To 50 Mg Atc Who M01ab05,Dak-G /Kkh Active Ingredient Efavirenz Atc Who J05ag03,Dak-G /Kkh Active Ingredient Eplerenone Atc Who C03da04,Dak-G /Kkh Active Ingredient Fampridine Atc Who N07xx07,Dak-G /Kkh Active Ingredient Fluorouracil, Combinations Atc Who L01bc52,Dak-G /Kkh Active Ingredient Fluticasone And Azelastine Rx Atc Who R01ad58,Dak-G /Kkh Active Ingredient Hydrochlorothiazide Atc Who C03aa03,Dak-G /Kkh Active Ingredient Hydromorphone Parenteral Atc Who N02aa03,Dak-G /Kkh Active Ingredient Hydromorphone Hkp Atc Who N02aa03,Dak-G /Kkh Active Ingredient Hydromorphone Sustained Release Atc Who N02aa03,Dak-G /Kkh Active Ingredient Levodopa In Combination With Benserazide Unretarded Atc Who N04ba02,Dak-G /Kkh Active Ingredient Levodopa In Combination With Benserazide, Retarded Atc Who N04ba02,Dak-G /Kkh Active Ingredient Levodopa In Combination With Carbidopa Unretarded Atc Who N04ba02,Dak-G /Kkh Active Ingredient Levodopa In Combination With Carbidopa Retarded Atc Who N04ba02,Dak-G /Kkh Active Ingredient Levodopa In Combination With Carbidopa And Entacapone Unretarded Atc Who N04ba03,Dak-G /Kkh Active Ingredient Metformin Atc Who A10ba02,Dak-G /Kkh Active Ingredient Methylphenidate Ret Atc Who N06ba04,Dak-G /Kkh Active Ingredient Methylphenidate Tab Atc Who N06ba04,Dak-G /Kkh Active Ingredient Methylphenidate Hvw, 30% Rapid Release, 70% Sustained Release Atc Who N06ba04,Dak-G /Kkh Active Ingredient Methylphenidate Hvw And Ret, 50% Rapid Release, 50% Sustained Release Atc Who N06ba04,Dak-G /Kkh Active Ingredient Metoclopramide Solid Atc Who A03fa01,Dak-G /Kkh Active Ingredient Metoprolol Tartrate Atc Who C07ab02,Dak-G /Kkh Active Ingredient Metoprolol Succinate Atc Who C07ab02,Dak-G /Kkh Active Ingredient Mianserin Atc Who N06ax03,Dak-G /Kkh Wirkstoff Milnacipran Atc Who N
|
